tiprankstipranks
Revolution Medicines (RVMD)
NASDAQ:RVMD
US Market

Revolution Medicines (RVMD) Income Statement

Compare
362 Followers

Revolution Medicines Income Statement

Last quarter (Q3 2024), Revolution Medicines's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Revolution Medicines's net income was $-156.29M. See Revolution Medicines’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 11.58M$ 35.38M$ 29.39M$ 42.98M$ 50.04M
Gross Profit
$ 11.58M$ 25.72M$ 22.06M$ -89.27M$ -41.71M
Operating Expenses
$ 498.76M$ 293.66M$ 217.40M$ 153.68M$ 104.16M
Depreciation and Amortization
$ 9.31M$ 9.66M$ 7.33M$ 6.54M$ 3.34M
EBITDA
$ -430.58M$ -239.47M$ -179.75M$ -101.91M$ -48.59M
Operating Income
$ -487.19M$ -258.28M$ -188.01M$ -110.70M$ -54.12M
Other Income/Expenses
$ 47.29M$ 9.15M$ 917.00K$ 2.17M$ 2.08M
Pretax Income
$ -439.89M$ -249.13M$ -187.09M$ -108.53M$ -52.04M
Net Income
$ -436.37M$ -248.71M$ -179.77M$ -108.16M$ -47.66M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.86$ -3.08$ -2.47$ -1.62$ -0.81
Diluted EPS
$ -3.86$ -3.08$ -2.47$ -1.62$ -0.81
Weighted Average Shares Outstanding
113.15M 80.63M 72.81M 66.60M 59.00M
Weighted Average Shares Outstanding (Diluted)
113.15M 80.63M 72.81M 66.60M 59.00M
Currency in USD

Revolution Medicines Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis